At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 177 enrolled
Drug / intervention
Mindfulness-Based Stress Reduction (MBSR) +1 morebehavioral
Likely dose
8-week MBSR course (behavioral intervention; no pharmacologic dose applicable)AI-extracted
Key inclusion· 5
- ✓HIV-positive with detectable viral load (>100 copies/mL)
- ✓CD4 T-cell count >250 cells/μL
- ✓Not currently on antiretroviral therapy (ART)
- ✓Ability to speak English
Key exclusion· 6
- ✕Recent ART use within the past 120 days
- ✕Any substance abuse, mental health, or medical condition that in the PI's opinion would impair participation
- ✕Plans to initiate ART within the next 12 months
- ✕Previous MBSR training or current meditation practice
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Mindfulness-Based Stress Reduction (MBSR), Stress Arousal and Immune Response in Early HIV
In Brief
A Phase 2 clinical trial evaluating Mindfulness-Based Stress Reduction (MBSR) and HIV-education and self-management workshop for HIV. Completed, enrolled 177 participants across 1 site.
Detailed Summary
To examine the effects of Mindfulness-Based Stress Reduction (MBSR) and education groups on HIV (Human Immunodeficiency Syndrome) infection. Key outcomes include CD4 and viral load, stress hormones, depression and quality of life.
Study Details
Timeline
Phase 2CompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartMay 2005
First PostedJan 2006
Primary CompletionSep 2009
TodayJul 2026
First PostedJan 4, 2006
Enrollment StartMay 1, 2005
Primary CompletionSep 1, 2009
TodayJul 2, 2026
Enrollment to primary: 4.3 yearsPosted 20.5 years ago
Interventions
Mindfulness-Based Stress Reduction (MBSR)behavioral
8 week MBSR course
HIV-education and self-management workshopbehavioral
8-week group covering a variety of educational topics about managing HIV infection.